New evidence for statins in VTE

While lack of evidence from recent meta-analyses reviewing the drugs’ anti-clotting effects dampened early enthusiasm for broadening their indication, the new study may tip the balance in favour of revising guidelines, an Australian expert suggests.

Professor John Fletcher, chairman of the Australia and New Zealand Working Party on the Management and Prevention of Venous Thromboembolism, said the study provided “fairly strong confirmatory evidence” that statins could be useful in preventing a first VTE.

“That association first came